Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.C400100200 on March 31, 2004

J. Biol. Chem., Vol. 279, Issue 21, 21774-21778, May 21, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/21/21774    most recent
C400100200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shi, H.
Right arrow Articles by Wang, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shi, H.
Right arrow Articles by Wang, Z.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The M3 Receptor-mediated K+ Current (IKM3), a Gq Protein-coupled K+ Channel*

Hong Shi{ddagger}§, Huizhen Wang{ddagger}§, Baofeng Yang||, Donghui Xu**, and Zhiguo Wang{ddagger}{ddagger}{ddagger}§§

From the {ddagger}Research Center, Montreal Heart Institute, Montreal, Quebec H1T 1C8, Canada, the {ddagger}{ddagger}Department of Medicine, University of Montreal, Montreal, Quebec H3C 3J7 Canada, the ||Pharmacology, Harbin Medical University, Harbin, Heilongjiang 150086 P. R. China, and the **School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, Guangdong 510275, People's Republic of China

Stimulation of muscarinic acetylcholine receptors (mAChRs) can activate an inward rectifier K+ current (IKACh), which is mediated by the M2 subtype of mAChR in cardiac myocytes. Recently, a novel delayed rectifier-like K+ current mediated by activation of the cardiac M3 receptors (designated IKM3) was identified, which is distinct from IKACh and other known K+ currents. While IKACh is known to be a Gi protein-gated K+ channel, the signal transduction mechanisms for IKM3 activation remained unexplored. We studied IKM3 with whole-cell patch clamp and macropatch clamp techniques. Whole cell IKM3 activated by choline persisted with minimal rundown over 2 h in presence of internal GTP. When GTP was replaced by guanyl-5'-yl thiophosphate, IKM3 demonstrated rapid and extensive rundown. While IKACh (induced by ACh) was markedly reduced in cells pretreated with pertussis toxin, IKM3 was unaltered. Intracellular application of antibodies targeting {alpha}-subunit of Gi/o protein suppressed IKACh without affecting IKM3. Antibodies targeting the N and the C terminus, respectively, of Gq protein {alpha}-subunit substantially depressed IKM3 but failed to alter IKACh. The antibody against {beta}-subunits of G proteins inhibited both IKACh and IKM3. IKM3 activated by choline in the cell-attached mode of macropatches persisted in the cell-free configuration. Application of purified Gq protein {alpha}-subunit or {beta}{gamma}-subunit of G proteins or guanosine 5'-O-(thiotriphosphate) to the internal solution activated IKM3-like currents in inside-out patches. Our findings revealed a novel aspect of receptor-channel signal transduction mechanisms, and IKM3 represents the first Gq protein-coupled K+ channel. We propose that the G protein-coupled K+ channel family could be divided into two subfamilies: Gi protein-coupled K+ channel subfamily and Gq protein-coupled K+ channel subfamily.


Received for publication, March 4, 2004 , and in revised form, March 24, 2004.

* This work was supported in part by the Heart and Stroke Foundation of Quebec and the Fonds de la Recherche de l'Institut de Cardiologie de Montreal (awarded to Z. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ These two contributed equally to this work and are both Research fellows of the Canadian Institute of Health Research during the study.

Current address: Bristol Myers Squibb Co., Pharmaceutical Research Inst., P. O. Box 5400, 311 Pennington-Rocky Hill Rd., Princeton, NJ 08543.

§§ A research scholar of the Fonds de Recherche en Sante de Quebec. To whom correspondence should be addressed: Research Center, Montreal Heart Inst., 5000 Belanger East, Montreal, Quebec H1T 1C8, Canada. Tel.: 514-376-3330 (ext. 3517); Fax: 514-376-1355; E-mail: wangz{at}icm.umontreal.ca.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement